Veterinary Infectious Disease Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Veterinary Infectious Disease Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


The global veterinary infectious disease diagnostics market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 8.50% during 2022-2028.

Farm and companion animals are commonly exposed to diseases that can spread to humans and cause zoonotic diseases. As a result, various veterinary infectious disease diagnostic technologies are used to evaluate the health of animals, detect diseases, provide effective treatment, and reduce the risk of cross-contamination. These technologies generally include cytology, bacteriological culture, immunohistochemical stains, fecal examination, and nucleic acid amplification. They are cost-effective, easy to use and have high-throughput detection capabilities. Furthermore, with the advent of molecular diagnostics, such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), microarrays, and sequencing technologies, the characterization of new, unknown viruses can be achieved.

Veterinary Infectious Disease Diagnostics Market Trends:
The rising trend of nuclear families and inflating income levels are significantly contributing to the adoption of companion animals and influencing pet ownership and humanization worldwide. This represents one of the key factors fueling the market growth. Moreover, the increasing sales of pet insurance on account of the growing concerns among pet parents about the well-being of their pets is catalyzing the demand for veterinary diagnostics to detect infectious diseases. Besides this, the increasing consumption of animal-derived products around the world, along with rising concerns about food safety and the growing instances of zoonotic diseases among animals, is driving the market. Veterinary infectious disease diagnostics services monitor the health of agricultural animals and prevent human exposure to diseases. This, along with the spread of coronavirus disease (COVID-19) across the globe, has resulted in considerable growth in PCR testing to analyze the effect of the infection in animals. Apart from this, governing agencies of numerous countries are supporting veterinary practices and commercial animal-production programs, which is promoting the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary infectious disease diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technology, animal type, infection type and end user.

Breakup by Technology:

Immunodiagnostics
Molecular Diagnostics
Others

Breakup by Animal Type:

Companion Animals
Food Producing Animals

Breakup by Infection Type:

Bacterial Infections
Viral Infections
Parasitic Infections
Others

Breakup by End User:

Reference Laboratories
Veterinary Laboratories and Clinics
Point of Care/In House Testing
Research Institutes and Universities

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Biomérieux SA, Creative Diagnostics, HESKA Corporation, Innovative Diagnostics, IDEXX Laboratories Inc., Neogen Corporation, Qiagen N.V., Randox Laboratories Ltd, Thermo Fisher Scientific Inc and Virbac.

Key Questions Answered in This Report:
How has the global veterinary infectious disease diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global veterinary infectious disease diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the animal type?
What is the breakup of the market based on the infection type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global veterinary infectious disease diagnostics market and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Veterinary Infectious Disease Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technology
6.1 Immunodiagnostics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Molecular Diagnostics
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Animal Type
7.1 Companion Animals
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Food Producing Animals
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Infection Type
8.1 Bacterial Infections
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Viral Infections
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Parasitic Infections
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Reference Laboratories
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Veterinary Laboratories and Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Point of Care/In House Testing
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Research Institutes and Universities
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Biomérieux SA
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Creative Diagnostics
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 HESKA Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Innovative Diagnostics
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 IDEXX Laboratories Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Neogen Corporation
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Qiagen N.V.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Randox Laboratories Ltd
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Thermo Fisher Scientific Inc
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Virbac
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings